12.05.2023
13:30 - 13:45
HALL A

OPENING CEREMONY

*Scientific Chair : Muhlis Cem Ar , İstanbul Üniversitesi - Cerrahpaşa, İstanbul Reyhan Küçükkaya , Türkiye
12.05.2023
13:45 - 14:00
HALL A

BREAK

12.05.2023
14:00 - 15:30
HALL A

INDOLENT LYMPHOMAS

*Scientific Chair : Eva Kimby , Karolinska Institute, Sweden Elif Birtaş Ateşoğlu , Yeditepe Üniversitesi, İstanbul
Follicular Lymphoma Eva Kimby, Karolinska Institute, Sweden
Marginal Zone Lymphoma Catherine Thieblemont, Hôpital Saint-Louis, France
Cell-Therapies in Indolent Lymphomas Koen Van Besien, UH Seidman Cancer Center, USA
HALL B

PEDIATRIC LEUKEMIAS-I

*Scientific Chair : Christian M Zwaan , Princess Máxima Center, Netherlands Ülker Koçak , Gazi Üniversitesi, Ankara
Ped AL Project Christian M Zwaan, Princess Máxima Center, Netherlands
Pediatric Studies With Inotuzumab Ozagamicin Edoardo Pennesi, Princess Máxima Center, Netherlands
Studies on Precision Dosing of ATMPs Caroline Lindemans, Princess Máxima Center, Netherlands
12.05.2023
15:30 - 16:00

BREAK

12.05.2023
16:00 - 17:30
HALL A

MYELOPROLIFERATIVE DISORDERS

*Scientific Chair : Elisabetta Abruzzese , S. Eugenio University Hospital, Italy Ahmet Emre Eşkazan , İstanbul Üniversitesi - Cerrahpaşa, İstanbul (Turkey)
Limits and Advances in TFR, Data From National Italian Registry Carmen Fava, University of Turin, Italy
Digital PCR and Its Future Role in CML Simona Bernardi, University of Brescia, Italy
CML Diagnosed During Pregnancy: How To Manage a Challenging Situation Ekaterina Chelysheva, National Research Center for Hematology, Russia
HALL B

PEDIATRIC LEUKEMIAS-II

*Scientific Chair : Gertjan J. L. Kaspers , Amsterdam UMC University Medical Centers, Netherlands Adalet Meral Güneş , Bursa Uludağ Üniversitesi, Bursa
Pediatric ALL Mats Heyman, Karolinska Institute, Sweden
Pediatric AML Gertjan J. L. Kaspers, Amsterdam UMC University Medical Centers, Netherlands
Pediatric APL Matthew Kutny, University of Alabama at Birmingham, USA
12.05.2023
17:30 - 18:00

BREAK

12.05.2023
18:00 - 19:30
HALL A

MULTIPLE MYELOMA

*Scientific Chair : Saad Usmani , Memorial Sloan Kettering Cancer Center, USA Meral Beksaç , Dr. , Liv Hospital, Ankara
Future Management of Smoldering MM Marivi Mateos, University Hospital of Salamanca, Spain
Future Management of Transplant Eligible NDMM Amrita Krishnan, City of Hope Comprehensive Cancer Center, USA
Future Management of Transplant Ineligible NDMM Saad Usmani, Memorial Sloan Kettering Cancer Center, USA
12.05.2023
19:30 - 20:00
HALL A

BREAK

12.05.2023
20:00 - 21:30
HALL A

ACUTE MYELOID LEUKEMIA

*Scientific Chair : Naval Daver , The University of Texas MD Anderson Cancer Center, USA İnci Alacacıoğlu , Dokuz Eylül Üniversitesi, İzmir
Improving Approaches To Transplant and Post-transplant Approaches in AML Charles Craddock, University of Birmingham, United Kingdom
Updates and Developments in The Treatment of Frontline Older/Unfit AML Tapan Kadia, Md Anderson Cancer Center, USA
Current Status and Novel Combinations With FLT3 Inhibitor Based Therapies in AML Jessica Altman, Northwestern University, USA
13.05.2023
10:30 - 12:00
HALL A

ACUTE LYMPHOBLASTIC LEUKEMIA

*Scientific Chair : Elizabeth Macintyre , Institut Necker Enfants-malades, France Mutlu Arat , Florence Nightingale Hospital, Türkiye
The European Working Group in Adult ALL - What Do We Do? Adele Fielding, University College London, United Kingdom
New EWALL Guidelines on Management of Adult ALL Nicola Gökbuget, Goethe University, Universitys Hospital, Frankfurt, Germany
Precision Diagnostics and Minimal Residual Disease Elizabeth Macintyre, Institut Necker Enfants-malades, France
EWALL-TARGET for Precision Therapy in Relapsed/Refractory T-ALL Philippe Rousselot, Versailles Saint-Quentin-en-Yvelines University, France
Round Table Discussion Between Panellists, Both Chairs and The Audience
13.05.2023
12:00 - 12:30

BREAK

13.05.2023
12:30 - 13:15
HALL A

ORAL PRESENTATIONS - I

*Scientific Chair : Şule Ünal Cangül , Hacettepe Üniversitesi, Ankara Neslihan Andıç , Eskişehir Osmangazi Üniversitesi, Eskişehir
INFECTION FREQUENCY AND DISTRIBUTION IN CASES USING KINASE INHIBITORS IN HEMATOLOGY: RETROSPECTIVE REAL-LIFE EXPERIENCE Hülya Yılmaz, Ankara University, Türkiye
INFECTIOUS COMPLICATIONS OF PEDIATRIC ALL PATIENTS IN A SINGLE CENTER WITH COMPARISON OF 2 TREATMENT PROTOCOLS Şule Ünal Cangül, Hacettepe Üniversitesi, Ankara
IS TGF-β1 AND SMAD-7 PREDICTIVE OF TREATMENT RESPONSE IN PATIENTS WITH LOW-RISK MDS AT THE TIME OF DIAGNOSIS? Bedrettin Orhan, Bursa Uludağ University, Türkiye (Turkey)
13.05.2023
13:15 - 13:45

BREAK

13.05.2023
13:45 - 15:15
HALL A

AGGRESSIVE LYMPHOMAS

*Scientific Chair : Graham Collins , University of Oxford, United Kingdom Ahmet Burhan Ferhanoğlu , Koç University, Turkey
Diffuse Large B-cell Lymphoma - Can We Beat R-CHOP? Graham Collins, University of Oxford, United Kingdom
Burkitt Lymphoma - Improving Outcomes Martine Chamuleau, Amsterdam UMC University Medical Centers, Netherlands
Primary Mediastinal B-cell Lymphoma - Progress in Frontline and Relapsed Disease David Sibon, Henri-Mondor University Hospital, France
13.05.2023
15:15 - 15:45

BREAK

13.05.2023
15:45 - 16:30
HALL A

ORAL PRESENTATIONS - II

*Scientific Chair : Leylagül Kaynar , Medipol Üniversitesi, İstanbul Özgür Mehtap , Kocaeli University, Türkiye
ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND/OR REFRACTORY HODGKIN LYMPHOMA:A MULTICENTER REAL WORLD EXPERIENCE Derya Koyun, Ankara University, Türkiye
THE EFFECT OF INTERLEUKIN-2 GENE POLYMORPHISMS (IL-2 RA, -330 T/G,+166 T/G) ON MULTIPLE MYELOMA Yasin Çolak, Ağrı Training and Research Hospital, Türkiye
THE CIRCULATING EXOSOMAL CD30 AND CD79B IN DLBCL: DOES IT INFLUENCE THE TARGETED THERAPY DECISION IN PRECISION MEDICINE? İkbal Cansu Barış, Pamukkale University, Türkiye
13.05.2023
16:30 - 17:00

BREAK

13.05.2023
17:00 - 18:30
HALL A

CHRONIC LYMPHOCYTIC LEUKEMIA

*Scientific Chair : Othman Al - Sawaf , University Hospital Of Cologne, Germany Fatih Demirkan , Dokuz Eylül Üniversitesi, İzmir
Covalent versus Non-Covalent BTKi - Implications for Treatment Sequencing Meghan Thompson, Memorial Sloan Kettering Cancer Center, USA
CLL Targets Beyond BTKi and Bcl2i Alexey Danilov, City of Hope Comprehensive Cancer Center, USA
Treatment Landscape of CLL in 2023 Othman Al - Sawaf, University Hospital Of Cologne, Germany
13.05.2023
18:30 - 19:00

BREAK

13.05.2023
19:00 - 20:30
HALL A

HODGKIN LYMPHOMA

*Scientific Chair : Jane Winter , Northwestern University, USA Muhit Özcan , Ankara Üniversitesi, Ankara
The New Face of Frontline Therapy Pamela Allen, Emory University School Of Medicine, USA
Relapsed Disease: Can We Do With Less? Jane Winter, Northwestern University, USA
Nodular Lymphocyte Predominant Hodgkin Lymphoma, a 2022 Update Pam Mckay, Beatson West of Scotland Cancer Center, Scothland
13.05.2023
20:30 - 20:45
HALL A

CLOSING REMARKS